China allows trial of investigators of GSK sex-tape scandal to go public

Arlene Weintraub China has abruptly changed course on its plans to prosecute private investigator Peter Humphrey and his wife Yu Yingzeng in a closed trial. Now Humphrey and Yu, who ...

Regado slips again as FDA weighs in on halted cardio trial

Damian Garde The FDA has stamped a full clinical hold on a trial Regado Biosciences had voluntarily paused, shouldering its way into any discussion of resuming the study and sending ...

Judge tosses decade-old investor suit against Pfizer and Celebrex weeks before trial

Eric Palmer A long-running and often contentious securities lawsuit tied to Pfizer's vilified pain drugs Celebrex and Bextra was set for a September trial, ...

Alzheimer’s R&D suffers as trial failure rate hits an ‘astounding’ 99.6%

John Carroll Jeffrey Cummings is directing one of the few early-stage studies underway on an Alzheimer's therapy. And now that he's scanned the records of clinicaltrials.gov, ...

EMA board agrees to approve revised trial data policy

Emily Mullin The management board of the European Medicines Agency (EMA) agreed on June 12 to approve a new policy that would require drug companies to share certain clinical trial ...

Eli Lilly gets on the trial transparency bandwagon

Damian Garde In keeping with changing industry standards, Eli Lilly has joined the host of drugmakers opening up their data vaults, going further than some but not quite baring it all. FierceBiotech ...

National Cancer Institute investigating trial outliers to resurrect ‘failed’ drugs

Emily Mullin After sifting through 10 years' worth of clinical trial data, NCI's Cancer Diagnosis Program says the program has identified about 100 "exceptional responders": ...

Aveo’s cancer drug circles the drain after a scuttled Phase II trial

Damian Garde Aveo Oncology and Astellas Pharma are shutting down a Phase II study of tivozanib in breast cancer after failing to enroll enough patients, the partners announced. FierceBiotech ...

Progenics tanks after two trial deaths cast doubt on its lead program

Damian Garde Two patients died of sepsis in a Phase II trial of Progenics Pharmaceuticals' in-development prostate cancer treatment, spurring concern that the drug is too toxic ...

Pluristem shines in stem cell trial for muscle injury

Damian Garde Israel's Pluristem Therapeutics is back in the spotlight with some positive results for its stem cell therapy in treating patients with a muscle injury, giving the ...

Peregrine Pharmaceuticals Starts Phase III Lung Cancer Trial

barbara.lempert Peregrine Pharmaceuticals Initiates Sunrise Pivotal Phase III Clinical Trial of Bavituximab in Second-Line Non-Small Cell Lung Cancer Company Launches www.SunriseTrial.com ...

Threshold Pharmaceuticals Achieves Target Enrollment in Phase III Sarcoma Trial

barbara.lempert Threshold Pharmaceuticals Announces Target Enrollment of 620 Patients Achieved in Pivotal Phase 3 Trial of TH-302 in Advanced Soft Tissue Sarcoma $ 12.5 Million USD ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS